Connection

ZHI TAN to Humans

This is a "connection" page, showing publications ZHI TAN has written about Humans.
Connection Strength

0.216
  1. The structure is the message: Preserving experimental context through tensor decomposition. Cell Syst. 2024 Aug 21; 15(8):679-693.
    View in: PubMed
    Score: 0.024
  2. SLO3 in the fast lane: The latest male contraceptive target with a promising small-molecule inhibitor. Proc Natl Acad Sci U S A. 2023 02 21; 120(8):e2221758120.
    View in: PubMed
    Score: 0.022
  3. The Pursuit of Enzyme Activation: A Snapshot of the Gold Rush. J Med Chem. 2022 11 10; 65(21):14289-14304.
    View in: PubMed
    Score: 0.021
  4. Tensor-structured decomposition improves systems serology analysis. Mol Syst Biol. 2021 09; 17(9):e10243.
    View in: PubMed
    Score: 0.020
  5. Comprehensive Modeling and Discovery of Mebendazole as a Novel TRAF2- and NCK-interacting Kinase Inhibitor. Sci Rep. 2016 09 21; 6:33534.
    View in: PubMed
    Score: 0.014
  6. Polypharmacology in Drug Development: A Minireview of Current Technologies. ChemMedChem. 2016 Jun 20; 11(12):1211-8.
    View in: PubMed
    Score: 0.014
  7. Editorial: The Elephant in the Room: Targeting Ras for Therapeutic Development. Mini Rev Med Chem. 2016; 16(5):343-4.
    View in: PubMed
    Score: 0.013
  8. Discovery of highly potent and ALK2/ALK1 selective kinase inhibitors using DNA-encoded chemistry technology. Proc Natl Acad Sci U S A. 2024 Nov 19; 121(47):e2413108121.
    View in: PubMed
    Score: 0.006
  9. On-demand modular assembly for expedited PROTAC development. Expert Opin Drug Discov. 2024 Jul; 19(7):769-772.
    View in: PubMed
    Score: 0.006
  10. Reversible male contraception by targeted inhibition of serine/threonine kinase 33. Science. 2024 05 24; 384(6698):885-890.
    View in: PubMed
    Score: 0.006
  11. Identification of potent pan-ephrin receptor kinase inhibitors using DNA-encoded chemistry technology. Proc Natl Acad Sci U S A. 2024 May 07; 121(19):e2322934121.
    View in: PubMed
    Score: 0.006
  12. CYP3A Mediates an Unusual C(sp2)-C(sp3) Bond Cleavage via Ipso-Addition of Oxygen in Drug Metabolism. Angew Chem Int Ed Engl. 2024 06 03; 63(23):e202405197.
    View in: PubMed
    Score: 0.006
  13. Tumor-associated nonmyelinating Schwann cell-expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusion. Sci Adv. 2023 02 03; 9(5):eadd6995.
    View in: PubMed
    Score: 0.005
  14. Discovery of Highly Potent and BMPR2-Selective Kinase Inhibitors Using DNA-Encoded Chemical Library Screening. J Med Chem. 2023 02 09; 66(3):2143-2160.
    View in: PubMed
    Score: 0.005
  15. Mechanisms of MCL-1 Protein Stability Induced by MCL-1 Antagonists in B-Cell Malignancies. Clin Cancer Res. 2023 01 17; 29(2):446-457.
    View in: PubMed
    Score: 0.005
  16. Discovery of potent BET bromodomain 1 stereoselective inhibitors using DNA-encoded chemical library selections. Proc Natl Acad Sci U S A. 2022 05 31; 119(22):e2122506119.
    View in: PubMed
    Score: 0.005
  17. DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 Mpro inhibitors. Proc Natl Acad Sci U S A. 2021 09 07; 118(36).
    View in: PubMed
    Score: 0.005
  18. A noncoding RNA modulator potentiates phenylalanine metabolism in mice. Science. 2021 08 06; 373(6555):662-673.
    View in: PubMed
    Score: 0.005
  19. Methylation of HSP70 Orchestrates Its Binding to and Stabilization of BCL2 mRNA and Renders Pancreatic Cancer Cells Resistant to Therapeutics. Cancer Res. 2020 10 15; 80(20):4500-4513.
    View in: PubMed
    Score: 0.005
  20. An up-to-date overview of computational polypharmacology in modern drug discovery. Expert Opin Drug Discov. 2020 09; 15(9):1025-1044.
    View in: PubMed
    Score: 0.004
  21. Circadian Regulator CLOCK Recruits Immune-Suppressive Microglia into the GBM Tumor Microenvironment. Cancer Discov. 2020 03; 10(3):371-381.
    View in: PubMed
    Score: 0.004
  22. Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer. Nature. 2019 04; 568(7752):410-414.
    View in: PubMed
    Score: 0.004
  23. Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer. Nat Med. 2018 05; 24(5):638-646.
    View in: PubMed
    Score: 0.004
  24. Computational polypharmacology: a new paradigm for drug discovery. Expert Opin Drug Discov. 2017 Mar; 12(3):279-291.
    View in: PubMed
    Score: 0.004
  25. Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth. Cell. 2016 11 17; 167(5):1281-1295.e18.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.